+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Contribution of exome sequencing for genetic diagnostic in arrhythmogenic right ventricular cardiomyopathy/dysplasia



Contribution of exome sequencing for genetic diagnostic in arrhythmogenic right ventricular cardiomyopathy/dysplasia



Plos one 12(8): E0181840



Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) is an inherited cardiomyopathy mainly caused by heterozygous desmosomal gene mutations, the major gene being PKP2. The genetic cause remains unknown in ~50% of probands with routine desmosomal gene screening. The aim of this study was to assess the diagnostic accuracy of whole exome sequencing (WES) in ARVC/D with negative genetic testing. WES was performed in 22 patients, all without a mutation identified in desmosomal genes. Putative pathogenic variants were screened in 96 candidate genes associated with other cardiomyopathies/channelopathies. The sequencing coverage depth of PKP2, DSP, DSG2, DSC2, JUP and TMEM43 exons was compared to the mean coverage distribution to detect large insertions/deletions. All suspected deletions were verified by real-time qPCR, Multiplex-Ligation-dependent-Probe-Amplification (MLPA) and cGH-Array. MLPA was performed in 50 additional gene-negative probands. Coverage-depth analysis from the 22 WES data identified two large heterozygous PKP2 deletions: one from exon 1 to 14 and one restricted to exon 4, confirmed by qPCR and MLPA. MLPA identified 2 additional PKP2 deletions (exon 1-7 and exon 1-14) in 50 additional probands confirming a significant frequency of large PKP2 deletions (5.7%) in gene-negative ARVC/D. Putative pathogenic heterozygous variants in EYA4, RBM20, PSEN1, and COX15 were identified in 4 unrelated probands. A rather high frequency (5.7%) of large PKP2 deletions, undetectable by Sanger sequencing, was detected as the cause of ARVC/D. Coverage-depth analysis through next-generation sequencing appears accurate to detect large deletions at the same time than conventional putative mutations in desmosomal and cardiomyopathy-associated genes.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059548034

Download citation: RISBibTeXText

PMID: 28767663


Related references

Compound and heterozygous mutations of DSG2 identified by Whole Exome Sequencing in arrhythmogenic right ventricular cardiomyopathy/dysplasia with ventricular tachycardia. Journal of Electrocardiology 51(5): 837-843, 2018

Exome sequencing in arrhythmogenic right ventricular cardiomyopathy: a new diagnostic tool?. Europace 19(6): 889-890, 2017

QRS fragmentation and epsilon waves in Fontaine leads in arrhythmogenic right ventricular cardiomyopathy: re: "The use of fontaine leads in the diagnosis of arrhythmogenic right ventricular dysplasia" and "Arrhythmogenic right ventricular cardiomyopathy: contribution of different electrocardiographic techniques". International Journal of Cardiology 176(3): 1015-1016, 2014

Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation. Molecular Genetics and Genomic Medicine 7(6): E593, 2019

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation 123(23): 2690-2700, 2011

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation. Circulation 101(11): E101-E106, 2000

Whole-Exome Sequencing Identifies a Novel Mutation of Desmocollin 2 in a Chinese Family With Arrhythmogenic Right Ventricular Cardiomyopathy. American Journal of Cardiology 119(9): 1485-1489, 2017

Whole-exome sequencing identifies a novel mutation of DSG2 (Y198C) in a Chinese arrhythmogenic right ventricular cardiomyopathy patient. International Journal of Cardiology 214: 1-3, 2016

Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy. International Journal of Cardiology 113(1): 4-11, 2006

P-456 Diagnostic value of ajmaline testing in arrhythmogenic right ventricular dysplasia-cardiomyopathy. Europace 4(Suppl. 2): B173-B173, 2010

Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient. Europace 21(1): 9-21, 2019

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: In search of a diagnostic electrocardiographic marker. Heart Rhythm 5(10): 1422-1423, 2008

QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Heart Rhythm 5(10): 1417-1421, 2008

Exercise-induced right ventricular dysplasia/cardiomyopathy--an emerging condition distinct from arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Lung and Circulation 18(3): 233-235, 2009

A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Human Mutation 30(9): 1278-1283, 2009